Fluoroquinolone pharmacodynamics and efficacy [2]

Chest

Volumn 120, Issue 1, 2001, Pages 319-320

  Doern, G V ^a   Tillotson, G S ^a   Karcic, A A ^a   Khan, F A ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; BLOOD LEVEL; CHRONIC BRONCHITIS; DISEASE EXACERBATION; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; HAEMOPHILUS INFLUENZAE; HUMAN; LETTER; LUNG PARENCHYMA; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 0034886359     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.1.319     Document Type: Letter

References (5)

1. AA Karcic FA Khan Ciprofloxacin in the treatment of pneumococcal lower respiratory tract infections: does it work? J Islam Med Assoc North Am 30 1998 83 89
2. BI Davies FP Maesen C Baur Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis Eur J Clin Microbiol 5 1986 226 231
3. BL Lee RC Kimbrough SR Jones Infectious complications with respiratory pathogens despite ciprofloxacin therapy N Engl J Med 25 1991 520 521
4. A Colville M Knowles D Large Fluoroquinolones in chronic obstructive pulmonary disease [letter] BMJ 308 1994 1437
5. E Bergogne-Berezin G Berthelot P Even Penetration of ciprofloxacin into bronchial secretions Eur J Clin Microbiol 5 1986 197 200